Innovative researchers win inaugural Sobi awards
Sobi has announced the winners of the inaugural Sobi Scientific Innovation Awards: Assistant Professor Víctor Jiménez-Yuste from Madrid, Spain and Dr Davide Matino from Hamilton, Canada. Their work has been recognised for elevating understanding of haemophilia and raising the standard of care, helping patients live a life beyond haemophilia
The Sobi Scientific Innovation Awards aim to recognise innovation and scientific excellence for both established and up-and-coming researchers. This year the focus was on haemophilia research, with prizes for Clinical and Pre-Clinical work.
Professor Jiménez-Yuste won the Clinical prize for his research on “The role of synovial, bone and cartilage biomarkers in the assessment of subclinical joint damage in young patients with severe haemophilia”.
Dr Matino was given the Pre-Clinical prize for his research on “Investigation of B regulatory cells capacity in haemophilia A complicated by inhibitors”, a project which was also co-authored by Professor Giancarlo Castaman.
Armin Reininger, Head of Medical and Scientific Affairs at Sobi, says the awards focus on research that reflects a meaningful difference for patients.
“I congratulate both our winners, and thank everyone who submitted their research,” he says.
“We are proud to support Investigator-Sponsored Studies because the research conducted by the community adds substantially to an increased understanding of pre-clinical and clinical value of haemophilia treatment.
“With these inaugural awards, we hope to encourage existing and up-and-coming researchers in this field to share new insights and strong results that that can elevate our understanding of haemophilia and raise the standard of care, thereby helping patients live a life beyond haemophilia.”
Submissions for the Innovation Awards were invited from healthcare professionals working in the field of haemophilia, who have an ongoing Sobi Investigator Sponsored Study (ISS), or who are a recipient of a Sobi Medical Grant.
Entries were assessed by the Adjudication Committee of independent, international haemophilia experts, according to scientific credit and contribution to haemophilia, overall concept novelty, as well as the anticipated ability of the research work to help liberate life for people with haemophilia.
The awards were presented at a ceremony in Amsterdam on the 18 October.
Víctor Jiménez-Yuste is an Associate Professor in the Haematology Department at the Autónoma University of Madrid, Spain, and Head of the Haematology Department at La Paz University Hospital, Madrid. After his medical degree at Valladolid University, Spain, Professor Jiménez-Yuste specialised in haematology at La Paz University Hospital, Madrid, Spain. He was awarded his PhD by the Autónoma University of Madrid where he completed his thesis studying haemophilia and HIV infection.
Professor Jiménez-Yuste is a member of the executive committee of the Spanish Society of Thrombosis and Haemostasis and EAHAD. His research interests include the management of inherited bleeding disorders, immune thrombocytopenia (ITP) and acquired haemophilia, and he has published more than 70 papers in various journals covering these issues.
Professor Jiménez-Yuste was represented at the ceremony by colleague Ihosvany Fernández-Bello.
Dr Davide Matino
Dr Davide Matino is a Clinical Research Fellow at the Thrombosis & Atherosclerosis Research Institute, Department of Medicine, McMaster University, Hamilton, Canada.
After obtaining his medical degree at the University of Perugia Medical School and his residency training at the University of Rome “Tor Vergata” in 2014, he completed a Clinical Fellowship in Bleeding Disorders at McMaster University. He then joined the University of Perugia as Assistant Professor in Pharmacology working on a research project focused on the study of the immune response to factor VIII in haemophilia, funded through a Young Investigator Award from the Italian Ministry of Health.
His research focused on inhibitor development in haemophilia, the treatment of inherited bleeding disorders, dendritic cells (DCs), adaptive immunity and immunotolerance mechanisms.
His work has received several awards and been presented both nationally and internationally at the International Society for Thrombosis and Haemostasis, American Society of Hematology, Italian Society of Hemophilia Centers and other scientific meetings.